IL-37 Inhibits Inflammasome Activation and Disease Severity in Murine Aspergillosis

Silvia Moretti(University of Perugia), Luigina Romani(University of Perugia), Giorgia Renga(University of Perugia), Charles A. Dinarello(University of Colorado Anschutz Medical Campus), Andrea Casagrande(Istituto Superiore di Sanità), Cecília Garlanda(Humanitas University), Matteo Puccetti(University of Perugia), Suzhao Li(University of Colorado Denver), Rossana G. Iannitti(Fidia Farmaceutici (Italy)), Frank L. van de Veerdonk(Radboud University Nijmegen), Vasileios Oikonomou(National Institutes of Health), Soohyun Kim(Ulsan National Institute of Science and Technology), Silvia Bozza(University of Perugia)
PLoS Pathogens
November 6, 2014
10.1371/journal.ppat.1004462
Cited by 164

Related Papers

Macrophages as tools and targets in cancer therapy
|Nature Reviews Drug Discovery|2022|1.7k
Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19
|JAMA|2020|884
Interleukin-1 Receptor Blockade Is Associated With Reduced Mortality in Sepsis Patients With Features of Macrophage Activation Syndrome
|Critical Care Medicine|2015|858
Presence of Genetic Variants Among Young Men With Severe COVID-19
|JAMA|2020|833
Differential requirement for the activation of the inflammasome for processing and release of IL-1β in monocytes and macrophages
|Blood|2008|777